Merck on the prowl for new drugs

  1. 255 Posts.
    lightbulb Created with Sketch. 35
    Merck CEO: Eager for Deals, Strong Prospects for New Drugs

    http://www.dddmag.com/news/2016/01/merck-ceo-eager-deals-strong-prospects-new-drugs

    "Merck's chief executive says the drugmaker is "raring to go" on deals this year, particularly for small and midsize acquisitions of companies or their experimental drugs. "

    Interesting to note that : "Frazier noted Merck did more deals last year than any in recent memory. About half of Merck sales come from drugs initially discovered by researchers elsewhere."

    It's nice to be on their radar this year ....
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.